US Bioservices now dispenses QINLOCK^TM (ripretinib)

QINLOCK^TM (ripretinib) is an oral kinase inhibitor indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with three or more kinase inhibitors, including imatinib.